Register for our free email digests:
Boston Scientific Corp.
www.bostonscientific.com
Latest From Boston Scientific Corp.
German Court Rules For Boston Scientific In TAVR Patent Tiff
A German court has issued a preliminary ruling favoring Boston Scientific in its most recent intellectual property dispute with Edwards LifeSciences. The ruling would allow Boston Scientific to block Edwards’ Sapien 3 Ultra from the German market.
A Chance To Own The Venous Space: BTG Acquires Novate
Complications with inferior vena cava (IVC) filters and subsequent patient-injury lawsuits have made this a tricky space for medical technology innovators, bu BTG has not been deterred. The UK company has entered the fray with a technology developed by Novate Medical, and as a bioconvertible product BTG believes it has key advantages compared with other offerings.
Market Intel: Martin Leon's TAVR Technology Tour Of The Future
Transcatheter aortic valve replacement pioneer Martin Leon discussed what is coming down the pike for technologies in the TAVR and heart valve device space at the recent Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego. Here is a run-down of what he highlighted, including AI-driven technologies that promise to improve patient access and outcomes. This is the first of a two-part series focusing on innovations in interventional cardiology.
Bringing The Clinician's Rationale Into The Heart Of Strategic Decision-Making At Boston Scientific
Boston Scientific Corp. has been back on the M&A trail in a big way in 2018, with a succession of strategic additions of various sizes that all have potential patient and shareholder impact across – and beyond – its established divisions. Chief medical officer of 18 months Ian Meredith explains the thought processes driving this policy, and the added dimension a CMO can bring to the overall question of strategy.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gynecological, Urological
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Cardiovascular Imaging Systems (CVIS)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
-
Boston Scientific Corp.
- Advanced Stent Technologies Inc.
- Apama Medical Inc.
- Asthmatx Inc.
- Atritech Inc.
- Bard Electrophysiology
- BEI Medical Systems Co. Inc.
- Boston Scientific Japan KK
- BridgePoint Medical Inc.
- Cameron Health Inc.
- Cardiac Pathways Corp.
- CardioGene Therapeutics Inc.
- Cardiovascular Imaging Systems Inc.
- Catheter Innovations Inc.
- Claret Medical Inc.
- Corvita Corp.
- CryoCor Inc.
- CryoVascular Systems Inc.
- Embolic Protection Inc.
- EndoChoice Holdings Inc.
- EndoTex Interventional Systems Inc.
- Enteric Medical Technologies Inc.
- EP Technologies Inc.
- Guidant Corp.
- Heart Technology Inc.
- InFlow Dynamics Inc.
- IntElect Medical Inc.
- Interventional Technologies Inc.
- IoGyn Inc.
- Labcoat Ltd.
- Mansfield
- Mansfield EP
- Meadox Medicals Inc.
- Microvasive Inc.
- MinTec
- nVision Medical Corp.
- Possis Medical Inc.
- Precision Vascular Systems Inc.
- Quanam Medical Corp.
- RadioTherapeutics Corp.
- Remon Medical Technologies Ltd.
- ReVascular Therapeutics Inc.
- Rhythmia Medical Inc.
- Rubicon Medical Corp.
- Sadra Medical Inc.
- Schneider Worldwide
- SciMed Life Systems Inc.
- Smart Therapeutics Inc.
- Symbiosis Corp.
- Symetis SA
- Target Therapeutics Inc.
- Vesica Medical Inc.
- Vessix Vascular Inc.
- XLumena Inc.
- Senior Management
-
Michael F Mahoney, Chmn. & CEO
Daniel J Brennan, EVP, CFO
Ian Meredith, EVP, Global CMO
Edward Mackey, MD, PhD, EVP, Global Operations - Contact Info
-
Boston Scientific Corp.
Phone: (508) 683-4000
300 Boston Scientific Way
Marlborough, MA 01752-1234
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice